Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMADEUS Atrial Fibrillation Monitoring in the Ablacure Database Including Patient-reported Outcomes and an Educational Program Used for Structured Care.

NCT03763500 is registered in ClinicalTrials.gov with Ulla Walfridsson as lead sponsor.

NCT NCT03763500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03763500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMADEUS Atrial Fibrillation Monitoring in the Ablacure Database Including Patient-reported Outcomes and an Educational Program Used for Structured Care.
Lead sponsor
Ulla Walfridsson
Phase
Not applicable
Overall status
Unknown status
Start date
December 3, 2018
Completion date
December 30, 2022
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, health economy, quality of life, signs and symptoms